Admelog
Admelog is a rapid-acting insulin analog used to improve blood sugar control in adults and children with diabetes mellitus. It is a biosimilar to insulin lispro, which means it is highly similar to an already approved biological medicine. Admelog is manufactured by Sanofi and was approved by the Food and Drug Administration (FDA) in 2017.
Medical Uses[edit | edit source]
Admelog is indicated for the treatment of type 1 diabetes in adults and children and type 2 diabetes in adults. It is typically administered via subcutaneous injection and can be used in insulin pumps for continuous subcutaneous insulin infusion (CSII). Admelog is designed to be taken shortly before meals to manage postprandial blood glucose levels.
Mechanism of Action[edit | edit source]
Admelog works by mimicking the action of natural insulin. It facilitates the uptake of glucose into cells, particularly in the liver, muscle, and fat tissue, thereby lowering blood glucose levels. The onset of action for Admelog is approximately 15 minutes, with a peak effect occurring between 30 minutes to 1 hour, and a duration of action of about 2 to 4 hours.
Administration[edit | edit source]
Admelog is administered via subcutaneous injection, typically in the abdomen, thigh, or upper arm. The injection site should be rotated within the same region to reduce the risk of lipodystrophy. It can also be administered using an insulin pump for continuous delivery.
Side Effects[edit | edit source]
Common side effects of Admelog include hypoglycemia, injection site reactions, and allergic reactions. Severe hypoglycemia can lead to symptoms such as confusion, seizures, and loss of consciousness. Patients are advised to monitor their blood glucose levels regularly to avoid hypoglycemia.
Storage[edit | edit source]
Unopened Admelog vials and pens should be stored in a refrigerator between 36°F to 46°F (2°C to 8°C). Once opened, they can be kept at room temperature, below 86°F (30°C), and should be used within 28 days.
Related Pages[edit | edit source]
| Diabetes Drug Stub | |
|---|---|
| |
| This article about a diabetes drug is a stub. You can help WikiMD by expanding it. | |
| Related topics | Diabetes mellitus · Insulin · Hypoglycemia · Hyperglycemia |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
